Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin

British Journal of Anaesthesia

Volumn 94, Issue 4, 2005, Pages 442-444

  Schalte G ^a   Janz, H ^b   Busse, J ^b   Jovanovic, V ^b   Rossaint, R ^a   Kuhlen, R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Stadtisches Klinikum   (Germany)

Author keywords

Cell, protection; Complications, anaemia; Complications, Jehovah's Witnesses; Hormones, erythropoietin

Indexed keywords

ERYTHROPOIETIN; FENTANYL; FOLIC ACID; HEMOGLOBIN; IRON; LIVER ENZYME; MIDAZOLAM; OXYGEN; PANCREAS ENZYME; RECOMBINANT ERYTHROPOIETIN; VITAMIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; EMERGENCY SURGERY; FEMALE; FINGER; HEMATOPOIESIS; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; JAUNDICE; LAPAROTOMY; MYOPATHY; OVARY CANCER; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUADRIPLEGIA; RELIGION; SKIN NECROSIS; TOE;

EID: 17044413743     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aei068     Document Type: Article

References (16)

1. Rasanayagam SR, Cooper GM. Two cases of severe postpartum anaemia in Jehovah's witnesses. Int J Obstet Anesth 1996; 5: 203-5
2. Busse J, Wesseling C. Tolerierung eines extremen intraoperativen Blutverlustes bei einer Zeugin Jehovas. Anasth Intensiv Notfallmed 1996; 31: 498-501
3. -1 with survival. Anaesth Intensive Care 1991; 19: 581-3
4. Cothren C, Moore EE, Offner PJ, et al. Blood substitute and erythopoietin therapy in a severely injured Jehovah's witness. New Engl J Med 2002; 346: 1097-8
5. Gillies IDS. Anaemia in relation to anaesthesia. In: Prys-Roberts; C, ed. The Circulation in Anaesthesia. Oxford: Blackwell Scientific Publications, 1980; 1227-30
6. Mathuru M, Kleinman B, Blakeman B, et al. Cardiovascular adjustments and gas exchange during extreme hemodilution in humans. Crit Care Med 1991; 19: 700-4
7. Zander R. Sauerstoffkonzentration und Säure-Basen-Status des arteriellen Blutes als limitierende Faktoren einer Hämodilution. Klin Wochenschr 1988; 66: 3-7
8. Zander R. Der arterielle Sauerstoff-Status als limitierender Faktor einer Hämodilution. Infusionstherapie 1990; 17: 20-3
9. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89: 4248-67
10. Corvin HL, Gettinger A, Rodriguez RM, et al. Efficacy of recombinant human erythropoietin in the critically ill patient. A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27: 2346-50
11. Siren AL, Fratteli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-9
12. Celik M, Gokman N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord injury. Proc Natl Acad Sci USA 2002; 99: 2258-63
13. Digicaylioglou M, Lipton SA. Erythropoietin mediated neuroprotection involves cross talk between Jak and NF-kappaB signal cascades. Nature 2001; 412: 641-7
14. Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002; 8: 495-505
15. Cai Z, Manolo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 107: 79-85
16. Parsa CJ, Matsumoto A, Kim J, et al. A novel effect of erythropoietin in the infarcted heart. J Clin Invest 2003; 112 999-1007